HAILEY STOKES: Open Payments
NPI 1760182950 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 111 payments from 14 companies in 2025. Trend: 2023 $689 · 2024 $1,280 · 2025 $2,535
Food & beverage: $2,318Education: $217
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $674 |
| Neurocrine BioSciences, Inc. | 19 | $507 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $425 |
| Otsuka America Pharmaceutical, Inc. | 13 | $185 |
| Axsome Therapeutics, Inc. | 3 | $162 |
| Vanda Pharmaceuticals Inc. | 9 | $161 |
| E.R. Squibb & Sons, L.L.C. | 11 | $149 |
| Alkermes, Inc. | 3 | $68 |
| ABBVIE INC. | 4 | $59 |
| Lundbeck LLC | 2 | $42 |
Products named: INGREZZA, CAPLYTA, UZEDY, AUSTEDO XR, Auvelity, FANAPT, COBENFY, REXULTI.
Industry payments across MS — which companies pay providers there.
